0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Next Generation Sequencing CLIA Laboratory Services Market by Service Type, Application, End User, Technology Platform, Sample Type - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715747
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Next Generation Sequencing CLIA Laboratory Services Market grew from USD 6.78 billion in 2024 to USD 7.71 billion in 2025. It is expected to continue growing at a CAGR of 13.54%, reaching USD 14.54 billion by 2030.

A New Era for CLIA-Accredited Sequencing Services

Modern clinical laboratories are witnessing a revolution driven by the rapid evolution of next generation sequencing within CLIA-accredited environments. These services have transcended traditional diagnostic boundaries to enable unprecedented precision in detecting genetic variants, informing treatment decisions, and advancing personalized medicine. Laboratories that once focused on single-gene assays now harness high-throughput sequencing platforms to deliver comprehensive genomic profiles, ranging from targeted gene panels to whole genome investigations.

Against this backdrop, decision-makers face a complex tapestry of technological innovations, regulatory updates, and shifting economic drivers. This executive summary distills critical developments shaping the market landscape, from the ripple effects of new tariff regimes to the nuanced segmentation of service offerings and end-user demands. It synthesizes expert interviews, rigorous secondary research, and in-depth analysis to provide actionable intelligence.

As clinical exome, targeted panels, and whole genome sequencing mature into standard-of-care modalities, stakeholders must navigate dynamic cost structures, evolving platform capabilities, and regional variations in adoption. This report equips laboratory directors, commercial leaders, and investors with a clear view of the forces propelling growth and the strategic imperatives required to thrive in an era of genomic innovation.

Emerging Forces Reshaping Next Generation Sequencing Labs

The next generation sequencing ecosystem is undergoing transformative shifts driven by technological breakthroughs, enhanced data analytics, and dynamic regulatory landscapes. Laboratory workflows are increasingly automated, with integrated sample preparation, sequencing, and bioinformatics pipelines reducing turnaround times and bolstering reproducibility. Coupled with advances in cloud computing and AI-enabled variant interpretation, these improvements are expanding the scalability of CLIA-accredited services.

At the same time, regulatory bodies are refining guidelines to ensure analytical validity and clinical utility. Enhanced quality control measures across sample types, from plasma to fresh frozen tissue, reinforce confidence in diagnostic outcomes. Moreover, the adoption of standardized data sharing frameworks is facilitating collaboration across research institutes, hospitals, and diagnostic laboratories, fuelling a virtuous cycle of innovation.

Economic pressures are also reshaping the landscape. Service providers are exploring strategic partnerships to optimize reagent supply chains, while platform manufacturers accelerate next-generation instrument rollouts that promise higher throughput and lower per-sample costs. As targeted gene panels extend into rare disease and oncology markets, and whole genome sequencing becomes more accessible, the market is poised for a profound realignment that rewards agility and scientific rigor.

Navigating the Ripple Effects of 2025 US Tariffs on Sequencing

The imposition of new tariff measures in 2025 has introduced a complex cost dynamic for next generation sequencing services within CLIA laboratories. Equipment imports, including high-throughput sequencing platforms, reagents, and ancillary consumables, have experienced increased duty burdens, compelling providers to revisit procurement strategies. In response, many laboratories are diversifying their supplier base, negotiating volume-based contracts, and localizing component sourcing to mitigate price escalations.

These tariff-induced cost adjustments have a direct bearing on service pricing models. Some providers have absorbed marginal increases to preserve market share, while others have implemented tiered pricing structures aligned with service complexity and turnaround expectations. Strategic investments in automation and platform consolidation further offset incremental tariff costs, enhancing operational resilience.

Crucially, the tariff environment has underscored the importance of supply chain transparency and risk assessment. Laboratories are conducting rigorous vendor audits and stress-testing scenarios to anticipate future disruptions. This heightened focus on supply chain agility and cost management will remain a defining characteristic of the CLIA sequencing market as geopolitical forces continue to influence cross-border trade.

Deep Dive into Service, Application and Technology Segmentation

Service type segmentation reveals distinct growth trajectories across clinical exome sequencing, targeted gene panel testing, and whole genome sequencing. Within clinical exome services, adult exome submissions have dominated routine diagnostics, whereas pediatric exome testing has rapidly expanded diagnostic yields for congenital disorders. Targeted panels, particularly those focused on oncology, cardiovascular health, and neurological disorders, are benefiting from streamlined interpretation pipelines. Hematologic panels and solid tumor panels, in particular, are establishing clinical utility benchmarks that drive adoption in oncology care. Whole genome sequencing, while still emerging, is carving out a niche in comprehensive variant discovery for complex cases.

Application-based segmentation underscores the diverse clinical value delivered by sequencing. Infectious disease testing is bifurcated into bacterial and viral pathogen identification, supporting antimicrobial stewardship and outbreak surveillance. Inherited disease workflows address both common and rare genetic conditions, improving diagnostic certainty and enabling gene-specific therapies. Oncology testing, spanning hematologic malignancies and solid tumors, provides actionable insights for targeted treatment regimens, while pharmacogenomics services optimize medication selection and dosing. Reproductive health offerings, from noninvasive prenatal testing to preimplantation genetic screening, are reshaping family planning through early detection and genetic risk assessment.

End user perspectives highlight variation in service adoption. Diagnostic laboratories leverage in-house capabilities to expand test menus, while direct-to-consumer providers focus on affordability and consumer education. Hospitals and clinics integrate sequencing into multidisciplinary care pathways, and research institutes utilize high-throughput platforms to accelerate discovery initiatives.

Technological platform segmentation illustrates competitive differentiation among major instrument manufacturers. BGI sequencing systems, including Bgiseq 500 and Mgiseq, deliver cost-effective throughput, whereas Illumina’s MiSeq, NextSeq, and NovaSeq platforms are prized for high accuracy and scalability. Thermo Fisher’s Ion Torrent PGM and Proton instruments cater to targeted applications requiring rapid turnaround and flexible lab integration.

Sample type considerations further refine service offerings. Blood-based assays, whether plasma or whole blood, are staples of liquid biopsy and prenatal screening. Saliva sampling provides a noninvasive route for genetic risk assessment, and tissue specimens, both FFPE and fresh frozen, support comprehensive tumor and hereditary analyses.

Divergent Growth Patterns Across Key Global Regions

Regional dynamics within the Americas reflect robust investment in clinical research and established reimbursement pathways for genomic testing. North American markets benefit from a matured regulatory infrastructure and a dense network of CLIA-certified laboratories, driving uptake of both targeted panels and broader exome services. In addition, Latin American countries are investing in public-private partnerships to bolster genomics capabilities, although challenges around infrastructure and policy harmonization persist.

The Europe, Middle East & Africa region presents a mosaic of adoption rates. Western European nations often lead in reimbursement and regulatory alignment, enabling widespread implementation of noninvasive prenatal testing and oncology panels. In contrast, certain Middle Eastern and African markets are accelerating capacity building through international collaborations and government-sponsored genomics initiatives, striving to translate next generation sequencing benefits into improved population health outcomes.

Asia-Pacific is characterized by rapid technological adoption and significant R&D investment. Nations across the region are establishing national genome programs and incentivizing local manufacturing to reduce dependency on imports. With a growing base of diagnostic laboratories and expanding healthcare infrastructure, Asia-Pacific laboratories are leveraging diverse sample types and application areas, from inherited disease diagnostics to infectious disease surveillance. This dynamic market continues to redefine competitive benchmarks for service quality and cost efficiency.

Strategic Moves by Leading Sequencing Service Providers

Leading sequencing service providers are executing differentiated strategies to secure market share and drive innovation. Platform manufacturers are investing heavily in next-generation instrument pipelines, focusing on enhanced throughput, lower cost per gigabase, and integrated bioinformatics solutions. Concurrently, laboratory service firms are forming strategic alliances with platform vendors and reagent suppliers to streamline end-to-end workflows, ensuring rapid assay deployment and robust quality control.

Partnerships between established molecular diagnostics companies and emerging specialty labs are delivering novel service bundles, combining targeted gene panels with advanced interpretation algorithms. Mergers and acquisitions activity remains intense as global and regional players seek to fill portfolio gaps in oncology, inherited disease, and pharmacogenomic offerings. These transactions not only expand geographic reach but also bolster laboratory capacity through shared infrastructure and validated protocols.

In parallel, several organizations are pioneering proprietary data management platforms that facilitate secure, compliant storage and real-time variant curation. By integrating clinical decision support tools, these companies enable physicians to act on genomic insights more confidently, further embedding sequencing services into standard care pathways. Such strategic moves underscore the importance of end-to-end solutions that marry technological excellence with actionable clinical insights.

Proactive Strategies to Strengthen Market Position and Resilience

Industry leaders must adopt a multi-pronged strategy to maintain competitiveness and foster sustainable growth. Prioritizing scalability through platform consolidation and automation will optimize cost structures, enabling labs to respond swiftly to shifts in demand and tariff landscapes. Forming cross-functional partnerships across reagent manufacturers, bioinformatics vendors, and clinical networks will expedite assay development, enhance data interoperability, and strengthen market positioning.

Expanding service portfolios to encompass both established and emerging applications-such as liquid biopsy for oncology and rapid infectious disease panels-will capture a broader share of clinical workflows. Laboratories should invest in continual personnel training and validation frameworks to ensure analytical and clinical validity across diverse sample types. Moreover, enhancing engagement with payers and regulatory stakeholders will streamline reimbursement pathways and elevate the perceived value of genomic services.

Finally, leveraging real-world evidence and health economics studies can demonstrate cost-effectiveness, driving payer coverage decisions and clinician adoption. By coupling rigorous performance data with patient outcome analyses, organizations can articulate the compelling case for next generation sequencing as a standard component of precision healthcare.

Robust Triangulation Methods Underpinning Our Analysis

This analysis is rooted in a rigorous research approach, integrating qualitative and quantitative methods to ensure robust findings. Primary insights were gathered through in-depth interviews with laboratory directors, platform executives, regulatory experts, and payers, offering a nuanced understanding of operational challenges and strategic priorities. Secondary data sources included peer-reviewed journals, regulatory filings, patent databases, and proprietary transaction records, ensuring comprehensive coverage of market dynamics.

Each data point underwent systematic validation through triangulation, cross-referencing vendor disclosures, clinical guideline updates, and reimbursement policy changes. Advanced analytics were employed to identify emerging trends, while expert panels provided interpretation to contextualize complex developments. The methodology emphasizes transparency, reproducibility, and impartiality, with iterative quality checks at every research milestone.

By adhering to these stringent protocols, the analysis delivers reliable, actionable insights into the evolving landscape of CLIA-accredited next generation sequencing services. Stakeholders can thus base critical decisions on a solid foundation of validated intelligence and methodological rigor.

Charting a Path Forward for CLIA Sequencing Services

The maturation of next generation sequencing within CLIA laboratory environments heralds a new chapter for precision diagnostics and personalized medicine. Key drivers-including advanced automation, integrated bioinformatics, and strategic supply chain optimization-are converging to deliver faster, more reliable results across a spectrum of clinical applications. Meanwhile, the evolving tariff landscape highlights the importance of procurement agility and cost management.

Segmentation insights reveal that service adoption varies significantly by type, application, end user, platform, and sample type, underscoring the need for tailored strategies. Regional perspectives demonstrate how regulatory frameworks, reimbursement policies, and local partnerships shape market trajectories. Leading companies continue to refine their offerings through strategic alliances, platform enhancements, and data-driven decision support solutions.

Looking ahead, laboratories that blend scientific rigor with operational excellence will capture the greatest value as next generation sequencing cements its role in mainstream healthcare. By embracing innovation, fostering collaborations, and articulating clear clinical and economic benefits, the industry stands poised to transform patient care on a global scale.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Service Type
    • Clinical Exome Sequencing
      • Adult Exome
      • Pediatric Exome
    • Targeted Gene Panel Testing
      • Cancer Panels
        • Hematologic Panels
        • Solid Tumor Panels
      • Cardiovascular Panels
      • Neurological Disorder Panels
    • Whole Genome Sequencing
  • Application
    • Infectious Disease
      • Bacterial Infections
      • Viral Infections
    • Inherited Disease
      • Common Disease
      • Rare Disease
    • Oncology
      • Hematologic Malignancies
      • Solid Tumor
    • Pharmacogenomics
    • Reproductive Health
      • Noninvasive Prenatal Testing
      • Preimplantation Genetic Testing
  • End User
    • Diagnostic Laboratories
    • Direct To Consumer Testing
    • Hospitals And Clinics
    • Research Institutes
  • Technology Platform
    • BGI Sequencing Platforms
      • Bgiseq 500
      • Mgiseq
    • Illumina Sequencing Platforms
      • MiSeq
      • NextSeq
      • NovaSeq
    • Thermo Fisher Sequencing Platforms
      • Ion Torrent Pgm
      • Ion Torrent Proton
  • Sample Type
    • Blood
      • Plasma
      • Whole Blood
    • Saliva
    • Tissue
      • Ffpe
      • Fresh Frozen
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Foundation Medicine, Inc.
  • Illumina Clinical Services Laboratory, Inc.
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • Fulgent Genetics, Inc.
  • Guardant Health, Inc.
  • Invitae Corporation
  • Veracyte, Inc.
  • Personalis, Inc.
  • Adaptive Biotechnologies Corporation

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Proliferation of communicable and noncommunicable disorders and need for diagnostic testing
5.1.1.2. Increasing government focus on enhancing disease screening and monitoring capabilities
5.1.1.3. Rising research and investments in cancer research
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals in diagnostic centers
5.1.3. Opportunities
5.1.3.1. Improvements in clinical utility and efficacy of genomic profiling with the NGS
5.1.3.2. Technological advances in next generation sequencing technologies
5.1.4. Challenges
5.1.4.1. Bioinformatics and computational complications in technology
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Next Generation Sequencing CLIA Laboratory Services Market, by Technology
6.1. Introduction
6.2. Cell Free DNA Sequencing
6.3. Metagenomic Sequencing
6.4. NGS Gene Panel Sequencing
6.5. Targeted Sequencing & Re-sequencing
6.6. Whole Exome Sequencing
6.7. Whole Genome Sequencing
7. Next Generation Sequencing CLIA Laboratory Services Market, by Certificate Types
7.1. Introduction
7.2. Certificate for Provider-Performed Microscopy Procedures
7.3. Certificate of Accreditation
7.4. Certificate of Compliance
7.5. Certificate of Registration
7.6. Certificate of Waiver
8. Next Generation Sequencing CLIA Laboratory Services Market, by Application
8.1. Introduction
8.2. Biomarker Discovery
8.3. Diagnostics
8.4. Drug Discovery
8.5. Precision Medicine
9. Next Generation Sequencing CLIA Laboratory Services Market, by End-users
9.1. Introduction
9.2. Diagnostic Centers
9.3. Hospitals
10. Americas Next Generation Sequencing CLIA Laboratory Services Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Next Generation Sequencing CLIA Laboratory Services Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Next Generation Sequencing CLIA Laboratory Services Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET RESEARCH PROCESS
FIGURE 2. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET DYNAMICS
TABLE 7. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CELL FREE DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY NGS GENE PANEL SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TARGETED SEQUENCING & RE-SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE FOR PROVIDER-PERFORMED MICROSCOPY PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF ACCREDITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF REGISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE OF WAIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY PRECISION MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 43. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. CANADA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 45. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 47. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 56. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 61. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. AUSTRALIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 63. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 65. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. CHINA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 67. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 69. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. INDIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 73. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. INDONESIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 75. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 77. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. JAPAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 81. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 82. MALAYSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 85. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. PHILIPPINES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 89. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SINGAPORE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 93. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. SOUTH KOREA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 97. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. TAIWAN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 101. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. THAILAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 105. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. VIETNAM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 114. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. DENMARK NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 116. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 118. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. EGYPT NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 120. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 122. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. FINLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 124. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 126. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. FRANCE NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 128. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 130. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 131. GERMANY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 134. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. ISRAEL NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 136. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 138. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. ITALY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 146. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. NIGERIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 148. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 150. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. NORWAY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 152. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 154. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. POLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 156. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 158. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. QATAR NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 162. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 163. RUSSIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 167. SAUDI ARABIA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 174. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. SPAIN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 178. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SWEDEN NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 182. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. SWITZERLAND NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 184. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 186. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. TURKEY NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY CERTIFICATE TYPES, 2018-2030 (USD MILLION)
TABLE 194. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 196. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 197. NEXT GENERATION SEQUENCING CLIA LABORATORY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The companies profiled in this Next Generation Sequencing CLIA Laboratory Services market report include:
  • Foundation Medicine, Inc.
  • Illumina Clinical Services Laboratory, Inc.
  • Natera, Inc.
  • Myriad Genetics, Inc.
  • Fulgent Genetics, Inc.
  • Guardant Health, Inc.
  • Invitae Corporation
  • Veracyte, Inc.
  • Personalis, Inc.
  • Adaptive Biotechnologies Corporation

Methodology

Table Information

This website uses cookies to ensure you get the best experience. Learn more